Trianni Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Trianni Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11336
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Trianni Inc (Trianni) is a developer of fully human monoclonal antibodies that provides its propriety discovery platform. The company provides Trianni Mouse platform that holds engineered versions of three antibody-encoding genetic loci, namely, Heavy, Kappa, Lambda, and others. It enables the expression of antibodies with fully human variable domains, leveraging in vivo selection to improve antibody diversity and quality. Trianni works in partnership with pharmaceutical companies and other contract research providers such as Lake Pharma and Evotec for antibody drug discovery and development, approach guarantees efficient expression of the full human antibody repertoire. The company has research and administrative facilities in the San Francisco Bay Area, California and in Research Triangle Park, North Carolina, the US. Trianni is headquartered in San Francisco, California, the US.

Trianni Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Trianni Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Trianni Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Trianni Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Trianni Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Trianni Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Trianni Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Trianni Enters into Agreement with Massachusetts General Hospital 10
Trianni Enters into Agreement with Evotec 11
Trianni Forms Partnership with LakePharma 12
Licensing Agreements 13
Trianni Enters into Licensing Agreement with Simon Fraser University 13
Gilead Sciences Enters into Licensing Agreement with Trianni 14
Trianni Enters into Licensing Agreement with Straterx 15
Antibody Solutions Enters into Licensing Agreement with Trianni 16
Trianni Enters into Licensing Agreement with NovaRock Biotherapeutics 17
Enthera Enters into Licensing Agreement with Trianni 18
Olympic Protein Technologies Enters into Licensing Agreement with Trianni 19
Immunomic Therapeutics Enters into Licensing Agreement with Trianni 20
Magenta Therapeutics Enters into a Licensing Agreement with Trianni 21
Fred Hutchinson Cancer Research Center Enters into Licensing Agreement with Trianni 22
Trianni Enters into Licensing Agreement with GigaGen 23
Stanford University Enters into Licensing Agreement with Trianni for Trianni Mouse 24
Janssen Biotech Enters into Licensing Agreement with Trianni 25
Juno Therapeutics Enters into Licensing Agreement with Trianni 26
Achaogen Enters into Licensing Agreement with Trianni 27
Takeda And Trianni Enter Into Licensing Agreement For Trianni Transgenic Mouse Platform 28
Trianni Inc – Key Competitors 29
Trianni Inc – Key Employees 30
Trianni Inc – Locations And Subsidiaries 31
Head Office 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Trianni Inc, Pharmaceuticals & Healthcare, Key Facts 2
Trianni Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Trianni Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Trianni Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Trianni Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Trianni Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Trianni Enters into Agreement with Massachusetts General Hospital 10
Trianni Enters into Agreement with Evotec 11
Trianni Forms Partnership with LakePharma 12
Trianni Enters into Licensing Agreement with Simon Fraser University 13
Gilead Sciences Enters into Licensing Agreement with Trianni 14
Trianni Enters into Licensing Agreement with Straterx 15
Antibody Solutions Enters into Licensing Agreement with Trianni 16
Trianni Enters into Licensing Agreement with NovaRock Biotherapeutics 17
Enthera Enters into Licensing Agreement with Trianni 18
Olympic Protein Technologies Enters into Licensing Agreement with Trianni 19
Immunomic Therapeutics Enters into Licensing Agreement with Trianni 20
Magenta Therapeutics Enters into a Licensing Agreement with Trianni 21
Fred Hutchinson Cancer Research Center Enters into Licensing Agreement with Trianni 22
Trianni Enters into Licensing Agreement with GigaGen 23
Stanford University Enters into Licensing Agreement with Trianni for Trianni Mouse 24
Janssen Biotech Enters into Licensing Agreement with Trianni 25
Juno Therapeutics Enters into Licensing Agreement with Trianni 26
Achaogen Enters into Licensing Agreement with Trianni 27
Takeda And Trianni Enter Into Licensing Agreement For Trianni Transgenic Mouse Platform 28
Trianni Inc, Key Competitors 29
Trianni Inc, Key Employees 30

List of Figures
Trianni Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Trianni Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Trianni Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Trianni Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Trianni Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Trianni Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Trianni Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Trianni Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Trianni Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ShotSpotter Inc (SSTI):企業の財務・戦略的SWOT分析
    ShotSpotter Inc (SSTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Anteo Diagnostics Ltd (ADO):企業の製品パイプライン分析2018
    Summary Anteo Diagnostics Ltd (Anteo Diagnostics) is a leading medical technology company that develops and commercializes healthcare products. The company along with its subsidiaries provides immunoassays, in-vitro diagnostics, and point of care (PoC) tests to life sciences, bio-separation, clinica …
  • CareDx Inc (CDNA):企業の製品パイプライン分析
    Summary CareDx Inc (CareDx) formerly XDx Inc, is a molecular diagnostics company focused on the discovery, development, and commercialization of diagnostic solutions for transplant patients. The company offers products which include AlloMap, a noninvasive blood test used by clinicians to monitor and …
  • Cooper Tire & Rubber Co (CTB):企業の財務・戦略的SWOT分析
    Cooper Tire & Rubber Co (CTB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Bristol-Myers Squibb Co (BMY)-製薬・医療分野:企業M&A・提携分析
    Summary Bristol-Myers Squibb Company (BMS) is specialty biopharmaceutical company that carries out the discovery, development, licensing, manufacturing, marketing, distribution and sale of medicines to patients with serious diseases. Its primary focus is in cancer, cardiovascular, immunoscience and …
  • Associated Milk Producers Inc.:企業の戦略・SWOT・財務情報
    Associated Milk Producers Inc. - Strategy, SWOT and Corporate Finance Report Summary Associated Milk Producers Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Richelieu Hardware Ltd:企業の戦略・SWOT・財務情報
    Richelieu Hardware Ltd - Strategy, SWOT and Corporate Finance Report Summary Richelieu Hardware Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • PhotoMedex Inc (PHMD)-製薬・医療分野:企業M&A・提携分析
    Summary PhotoMedex Inc (PhotoMedex) is a medical device company that provides dermatological solutions. The company offers Neova, Tricomin and IAMIN products. Its products are used in the treatment of skin diseases and conditions such as psoriasis, vitiligo, acne, actinic keratosis. PhotoMedex provi …
  • Traverse Energy Ltd (TVL):石油・ガス:M&Aディール及び事業提携情報
    Summary Traverse Energy Ltd (Traverse Energy), formerly Firstland Energy Ltd is an oil and gas company that explores, produces, and develops petroleum and natural gas assets. The company's products include crude oil, natural gas, petroleum products, and associated liquids, among others. It explores …
  • JB Hi-Fi Limited (JBH):企業の財務・戦略的SWOT分析
    JB Hi-Fi Limited (JBH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Premaitha Health Plc (NIPT):医療機器:M&Aディール及び事業提携情報
    Summary Premaitha Health Plc (Premaitha Health), formerly Vialogy Plc, is a molecular diagnostics company, which focuses on the development of genetic screening tests including novel tests for non-invasive prenatal screening (NIPT). Its flagship product, the IONA test is an advanced NIPT test that a …
  • China Oilfield Services Ltd (2883):企業の財務・戦略的SWOT分析
    China Oilfield Services Ltd (2883) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Lees Foods Ltd.:企業の戦略・SWOT・財務情報
    Lees Foods Ltd. - Strategy, SWOT and Corporate Finance Report Summary Lees Foods Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Champions Oncology Inc (CSBR):企業の財務・戦略的SWOT分析
    Summary Champions Oncology Inc (Champions), formerly Champions Biotechnology Inc, is a developer of advanced technology solutions and services to personalize the development and use of oncology drugs. The company’s technology platform is an approach based upon the implantation of primary human tumor …
  • Enel Generacion Chile SA (ENELGXCH):電力:M&Aディール及び事業提携情報
    Summary Enel Generacion Chile SA (Enel Generacion), formerly Empresa Nacional de Electricidad SA, is a power utility. It generates, distributes and sells electricity, exports natural gas, and provides various energy related products and services. The company produces electricity using hydro, gas, fu …
  • Hino Motors, Ltd.:企業の戦略・SWOT・財務情報
    Hino Motors, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Hino Motors, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • MLM Biologics Inc:企業の製品パイプライン分析
    Summary MLM Biologics Inc (MLM Biologics) operates as a medical device company that provides optimum wound care management for patients and doctors. The company’s product includes bio-ConneKt Wound Matrix, a collagen-based wound dressing for chronic vascular ulcers, draining wounds, partial and full …
  • HeartSciences:医療機器:M&Aディール及び事業提携情報
    Summary HeartSciences, formerly Heart Test Laboratories Inc, is a medical device company that offers cardiac care products. The company develops, manufactures and markets cardiac testing tools for the early detection of heart disease. It offers MyoVista, a screening tool used to determine the presen …
  • Xtant Medical Holdings Inc (XTNT):企業の財務・戦略的SWOT分析
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings Inc, is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowr …
  • Colonial Pipeline Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Colonial Pipeline Co (Colonial) is an oil and gas company that distributes petroleum products. The company transports refined petroleum products such as gasoline, home-heating oil, kerosene, diesel fuels; and aviation fuel including jet fuel and military fuels. It provides services including …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆